Megace Es
Product Images NDC 17856-0949

4 FDA label images from Atlantic Biologicals Corps · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Megace Es (NDC 17856-0949). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ad5147c4 60e0 442f B4fd 41d1956d7724 01)

Chemical Structure (Ad5147c4 60e0 442f B4fd 41d1956d7724 01)
Chemical structure of megestrol acetate, the active ingredient in Megace ES by Atlantic Biologicals Corps, shown as a molecular diagram with carbon, hydrogen, and oxygen atoms arranged in a steroid framework.*
FDA Label Image

Figure 2: Mean Weight Change For Patients Evaluable For Efficacy (Ad5147c4 60e0 442f B4fd 41d1956d7724 02)

Figure 2: Mean Weight Change For Patients Evaluable For Efficacy (Ad5147c4 60e0 442f B4fd 41d1956d7724 02)
A line graph titled 'TRIAL 1' showing mean weight change in kilograms on the vertical axis and weeks (0, 4, 8, 12) on the horizontal axis. Four lines represent different dosages: 800 mg, 400 mg, 100 mg, and a placebo. The lines show increasing weight gain over time for 800 mg, 400 mg, and 100 mg doses, while the placebo group shows minimal change. Sample sizes at weeks 4, 8, and 12 are indicated below the x-axis.*
FDA Label Image

Figure 3: Mean Weight Change For Patients Evaluable For Efficacy In Trial 2 (Ad5147c4 60e0 442f B4fd 41d1956d7724 03)

Figure 3: Mean Weight Change For Patients Evaluable For Efficacy In Trial 2 (Ad5147c4 60e0 442f B4fd 41d1956d7724 03)
A line graph titled 'TRIAL 2' depicting mean weight change (kg) over a 12-week period. The x-axis represents weeks (0, 4, 8, 12) and the y-axis shows mean weight change in kilograms (-1 to 6). Two lines compare weight change for 800 mg treatment versus placebo, with weight increasing steadily for 800 mg and remaining near zero or declining for placebo.*
FDA Label Image

Label Image (Rspl17856 0949)

Label Image (Rspl17856 0949)
Text panel from Megace ES oral suspension displaying active ingredient Megestrol Acetate at 625 mg per 5 mL, with dosing instructions of 20 mL orally once daily. Also includes lot number, expiration date, distributor Atlantic Biologicals, and packaging location Miami, Florida.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.